Aigner R M, Fueger G F, Lax S
Department of Radiology, Karl-Franzens-University of Graz, Austria.
Nuklearmedizin. 1997 Oct;36(7):256-8.
Recent studies indicate that Tc-99m-Sestamibi (MIBI, DuPont Pharma) is a useful tracer for detecting parathyroid adenomas. We present a patient with focal Tc-99m-MIBI uptake in parathyroid carcinoma which has only been described once before (1). Tc-99m-MIBI scintigraphy may be considered for diagnosing pathological parathyroid tissue. But presently the histopathological examination only allows the differentiation between adenoma and carcinoma.
近期研究表明，锝-99m-甲氧基异丁基异腈（MIBI，杜邦制药公司）是检测甲状旁腺腺瘤的一种有用的示踪剂。我们报告一例甲状旁腺癌中出现局灶性锝-99m-MIBI摄取的患者，此前仅有一次相关报道(1)。锝-99m-MIBI闪烁扫描术可用于诊断病理性甲状旁腺组织。但目前组织病理学检查仅能区分腺瘤和癌。
